Pyoderma Gangrenosum and Tumor Necrosis Factor α Agents

Article Type
Article
Changed
Thu, 01/10/2019 - 13:10
Display Headline
Pyoderma Gangrenosum and Tumor Necrosis Factor α Agents
Author(s)
Efstathios Rallis, MD, PhD
Elma Koumantaki-Mathioudaki, MD, PhD
Amalia Tsiatoura, MD
Panagiotis Stavropoulos, MD, PhD
Andreas Katsambas, MD, PhD
Article PDF
CT092040001_e.pdf
Issue
Cutis - 92(4)
Publications
Cutis
MDedge Dermatology
Page Number
E1-E2
Legacy Keywords
ulcerative dermatosis, inflammatory bowel disease and pyoderma, IBD and pyoderma, IBD and anti-tumor necrosis factor alpha agents, irrital bowel disease and skin disease, skin lesions and IBD
Sections
Case Letter
Author(s)
Efstathios Rallis, MD, PhD
Elma Koumantaki-Mathioudaki, MD, PhD
Amalia Tsiatoura, MD
Panagiotis Stavropoulos, MD, PhD
Andreas Katsambas, MD, PhD
Author(s)
Efstathios Rallis, MD, PhD
Elma Koumantaki-Mathioudaki, MD, PhD
Amalia Tsiatoura, MD
Panagiotis Stavropoulos, MD, PhD
Andreas Katsambas, MD, PhD
Article PDF
CT092040001_e.pdf
Article PDF
CT092040001_e.pdf
Related Articles
Superficial Pyoderma Gangrenosum Treated With Infliximab: A Case Report
Issue
Cutis - 92(4)
Issue
Cutis - 92(4)
Page Number
E1-E2
Page Number
E1-E2
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Article Type
Article
Display Headline
Pyoderma Gangrenosum and Tumor Necrosis Factor α Agents
Display Headline
Pyoderma Gangrenosum and Tumor Necrosis Factor α Agents
Legacy Keywords
ulcerative dermatosis, inflammatory bowel disease and pyoderma, IBD and pyoderma, IBD and anti-tumor necrosis factor alpha agents, irrital bowel disease and skin disease, skin lesions and IBD
Legacy Keywords
ulcerative dermatosis, inflammatory bowel disease and pyoderma, IBD and pyoderma, IBD and anti-tumor necrosis factor alpha agents, irrital bowel disease and skin disease, skin lesions and IBD
Sections
Case Letter
Disallow All Ads
Alternative CME
Teaser Media
Article PDF Media
Subscribe to Amalia Tsiatoura, MD